Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01974063 · ClinicalTrials.gov registry record

Alternate Nicotine Delivery Systems and Airway Epithelial Biology

A clinical trial, sponsored by Weill Medical College of Cornell University.

Terminated
Registry status
96
Enrollment target

NCT01974063 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 96 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01974063 was terminated before completion, sponsored by Weill Medical College of Cornell University.

TERMINATED
Registry status
96 participants
Enrollment target

Study Summary

Cigarette smoking evokes major changes in the biology of the airway epithelium, the cell population that takes the brunt of the stress of cigarette smoke and the cell population central to the pathogenesis of chronic obstructive pulmonary disease (COPD) and lung cancer. The focus of this study is to identify the differences that two popular alternative nicotine delivery strategies, shisha and electronic cigarettes, have on the airway epithelium compared to cigarette smoking. We hypothesize that both alternative nicotine delivery strategies disorder airway epithelial biology, but in different ways than does cigarette smoking.

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2013-03
Est. Completion 2017-05

What the Registry Record Tells You About NCT01974063

The ClinicalTrials.gov registry entry for NCT01974063 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01974063 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01974063 about?

NCT01974063 is a clinical study titled "Alternate Nicotine Delivery Systems and Airway Epithelial Biology". Cigarette smoking evokes major changes in the biology of the airway epithelium, the cell population that takes the brunt of the stress of cigarette smoke and the cell population central to the pathogenesis of chronic obstructive pulmonary disease (COPD) and lung cancer. The focus of this study is to...

What is the current status of trial NCT01974063?

This trial is currently terminated. The enrollment target is 96 participants. The study started on 2013-03. Estimated completion is 2017-05.

Who is sponsoring clinical trial NCT01974063?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.